Dr. Jeff Ratliff talks with Dr. Ron Postuma about the clinical features associated with IGLON5 positivity, emphasizing the implications for practitioners in diagnosing and treating sleep and movement disorders.
IGLON5 Frequency in Idiopathic REM Sleep Behavior Disorder
Previous
Previous
Dr. Wolfgang Singer Named Professor of Neurology: Advancing Autonomic Research at Mayo Clinic
Next
Next